Drugs / Custodiol Htk Soln
last change Dec 2024 re-read 3 minutes ago

Custodiol Htk Soln

Developed for
cardiac arrest
Investigated by
Lourdes Montero Cruces

Trials 1

20252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT06530641 Dec 2024 → Nov 2026 expected cardiac arrest Lourdes Montero Cruces Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Custodiol Htk Soln ClinicalTrials.gov intervention name — accepted as the source's own label NCT06530641 ↗
Known as Custodiol HTK solution. ACT: K944866 “Custodiol HTK solution. ACT: K944866” NCT06530641 ↗